RAD51のm6AおよびPARylation修飾は、ベンゼン誘発性血液毒性を調整する
Lin Chen1, Fengzhen Cui1, Han Li1
1School of Public Health, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, Guangdong 523808, China.
Journal of hazardous materials
|December 31, 2025
まとめ
DNA修復タンパク質であるRAD51は、ベンゼン代謝物であるヒドロキノンによってアップレギュレーションされ、DNA損傷を抑制します。これは、RAD51が曝露された個人のベンゼン誘発性血液毒性のバイオマーカーとなる可能性を示唆しています。
科学分野:
- 環境保健
- 分子生物学
- 毒物学
背景:
- 職業的ベンゼン曝露は、白血病の既知の原因です。
- ベンゼン毒性に関連するDNA損傷修復におけるRAD51の役割は、よく理解されていません。
研究 の 目的:
- ベンゼン誘発性血液毒性におけるRAD51の役割を調査すること。
- ベンゼン曝露健康リスクを監視するための潜在的なバイオマーカーを特定すること。
主な方法:
- ベンゼン代謝物であるヒドロキノン(HQ)へのヒトリンパ芽球細胞(TK6)の曝露。
- RAD51発現とそのMETTL3およびYTHDC1による調節の分析。
- RAD51に対するPARP1媒介PARylationの調査。
- 職業的ベンゼン曝露作業者からのリンパ球におけるタンパク質発現の検査。
主要な成果:
- ヒドロキノン曝露はTK6細胞におけるRAD51発現をアップレギュレーションし、DNA損傷を抑制します。
- METTL3媒介のm6A修飾とYTHDC1結合はRAD51発現を増強します。
- PARP1媒介のPARylationは、HQ誘発性DNA損傷をさらに低減します。
- RAD51、PARP1、YTHDC1、およびMETTL3は、ベンゼン曝露作業者のリンパ球でアップレギュレーションされました。
結論:
- RAD51は、ヒドロキノン誘発性DNA損傷に対して保護的な役割を果たします。
- METTL3-YTHDC1経路は、ベンゼン代謝物曝露に応答してRAD51発現を調節します。
- RAD51は、曝露集団におけるベンゼン誘発性血液毒性を評価するためのバイオマーカーとして可能性を示します。
さらに関連する動画
関連する概念動画
Covalently Linked Protein Regulators
8.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.6K
Electrophilic Aromatic Substitution: Chlorination and Bromination of Benzene
10.5K
Chlorination and bromination are important classes of electrophilic aromatic substitutions, where benzene reacts with chlorine or bromine in the presence of a Lewis acid catalyst to give halogenated substitution products. A Lewis acid such as aluminium chloride or ferric chloride catalyzes the chlorination, and ferric bromide catalyzes the bromination reactions. During the bromination of alkenes, bromine polarizes and becomes electrophilic. However, in the bromination of benzene, the bromine...
10.5K
Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Electrophilic Aromatic Substitution: Sulfonation of Benzene
7.7K
Sulfonation of benzene is a reaction wherein benzene is treated with fuming sulfuric acid at room temperature to produce benzenesulfonic acid. Fuming sulfuric acid is a mixture of sulfur trioxide and concentrated sulfuric acid.
7.7K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Spontaneous and Induced Mutations
2.0K
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
2.0K


